Healthcare & Life Sciences
Cimeio Therapeutics
Cambridge, United Statescimeio.com
Cimeio Therapeutics is a Healthcare & Life Sciences startup based in Cambridge, the United States, most recent round Series C+, 2 tracked investors.
Activeseries-c-plus
series-c-plus
Stage
2020
Founded
2
Investors
About Cimeio Therapeutics
Cimeio Therapeutics is a company founded in 2020 headquartered in Cambridge, the United States. Its most recent tracked round is Series C+. Brouky classifies it under Healthcare & Life Sciences. Brouky records 2 investors associated with the company.
Cimeio Therapeutics develops a novel immunotherapy platform that pairs cell-shielding technology with precisely targeted immunotherapies, aiming to improve outcomes for patients with hematologic malignancies and autoimmune diseases.
Explore Cimeio Therapeutics's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.